Michaela Lehle

10.6k citations
41 papers · 7.6k · 4 hit papers · h-index 19

Impact in

    • Gastrointestinal Tumor Research and Treatment
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Hemophilia Treatment and Research 28
    • Platelet Disorders and Treatments 3
    • Chronic Myeloid Leukemia Treatments 2
    • HER2/EGFR in Cancer Research 9
    • Peptidase Inhibition and Analysis 2

Michaela Lehle

40 papers receiving 7.5k citations

Michaela Lehle's Hit Papers

Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study 2019 · 277 citations
2770+5+11Years since publication10002.0k3.0k4.0k5.0k

Peers

Michaela Lehle
Comparison fields: 5 of 98
  • Gastroenterology 688
  • Oncology 3.2k
  • Pulmonary and Respiratory Medicine 3.0k
  • Hematology 825
  • Cancer Research 641
Replace Petri Bono with:
Petri Bono Finland
Catherine Delbaldo France
A. Feyereislova Switzerland
Sandra Silberman United States
Jonathan Polikoff United States
Hans‐Ulrich Schildhaus Germany
Allen Lee Cohn United States
Daniel V.T. Catenacci United States
J. Randolph Hecht United States
Yasushi Omuro Japan
Michaela Lehle relative to Petri Bono Finland Petri Bono's profile →
Citations per field
00.5×5.6×
Petri Bono · 1×
Citations per year

Countries citing papers authored by Michaela Lehle

Since Specialization
Citations

This map shows the geographic impact of Michaela Lehle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Lehle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Lehle more than expected).

Fields of papers citing papers by Michaela Lehle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Lehle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Lehle. The network helps show where Michaela Lehle may publish in the future.

Co-authors

The 25 scholars most cited alongside Michaela Lehle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michaela Lehle Line = papers co-authored together Michaela Lehle links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Hit paper breakdown →
20105344
2
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
Hit paper breakdown →
2009598
3
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Hit paper breakdown →
2014437
4
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
Hit paper breakdown →
2019277
5 2020180
6 2009148
7 201488
8 200969
9 201055
10 202348
11 202338
12 202136
13 201934
14 202233
15 201928
16 200924
17 202122
18 201821
19 201319
20 200917

About Michaela Lehle

Michaela Lehle is a scholar working on Hematology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Surgery, having authored 41 papers that have together received 7.6k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (28 papers), HER2/EGFR in Cancer Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Gastric Cancer Management and Outcomes (4 papers), Platelet Disorders and Treatments (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Gastroenterology (688 citations), Oncology (3.2k citations), Pulmonary and Respiratory Medicine (3.0k citations), Hematology (825 citations) and Cancer Research (641 citations). Michaela Lehle has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include A. Feyereislova, Eric Van Cutsem, Yung‐Jue Bang, Julie Hill, Florian Lordick, Akira Sawaki, Josef Rüschoff, Yoon‐Koo Kang, Hyun Cheol Chung and Atsushi Ohtsu. Their work appears in journals such as Blood, Haemophilia, Journal of Clinical Oncology, Research and Practice in Thrombosis and Haemostasis and The Lancet Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact